Literature DB >> 15465091

Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission.

Kyoji Taguchi1, Jin Ren, Iku Utsunomiya, Hiroyuki Aoyagi, Nobuya Fujita, Toshio Ariga, Tadashi Miyatake, Hiide Yoshino.   

Abstract

We investigated the epitopes and functional role of IgG anti-GalNAc-GD1a antibodies appearing in serum from a patient with Guillain-Barre syndrome (GBS) and IgG anti-GalNAc-GD1a antibody that was produced by immunization of a rabbit with GalNAc-GD1a. Both sera blocked neuromuscular transmission in muscle-spinal cord co-culture cells. The acetylcholine-induced potential did not reduce by adding sera, suggesting that the blockade is presynaptic. The effect was complement-independent and purified IgG from serum of the patient or the rabbit had the same effects. The epitope with both anti-GalNAc-GD1a antibodies was observed in the soma of large neurons in the anterior horns of the adult rat spinal cord and their motor axons of rat ventral roots. Both anti-GalNAc GD1a antibodies reacted strongly with the motor nerve terminals in rats. The anti-GalNAc-GD1a antibodies may block neuromuscular transmission by attacking on presynaptic motor axon, probably affecting the ion channels in the presynaptic motor axon.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465091     DOI: 10.1016/j.jns.2004.07.011

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

1.  Effects of IgG anti-GM1 monoclonal antibodies on neuromuscular transmission and calcium channel binding in rat neuromuscular junctions.

Authors:  Sayako Hotta; Yoshihiko Nakatani; Toshie Kambe; Kenji Abe; Yutaka Masuda; Iku Utsumomiya; Kyoji Taguchi
Journal:  Exp Ther Med       Date:  2015-06-12       Impact factor: 2.447

Review 2.  Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases.

Authors:  Robert K Yu; Seigo Usuki; Toshio Ariga
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

3.  Neurophysiological and immunohistochemical studies of IgG anti-GM1 monoclonal antibody on neuromuscular transmission: effects in rat neuromuscular junctions.

Authors:  Sayako Hotta; Takumi Nagaoka; Kyoji Taguchi; Yoshihiko Nakatani; Iku Utsnomiya; Yutaka Masuda; Kenji Abe; Nobuhiro Yuki
Journal:  Neurol Sci       Date:  2013-07-03       Impact factor: 3.307

Review 4.  Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction.

Authors:  Jaap J Plomp; Hugh J Willison
Journal:  J Physiol       Date:  2009-06-29       Impact factor: 5.182

5.  Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barré syndrome and its variants.

Authors:  Michiaki Koga; Masaki Takahashi; Keiko Yokoyama; Takashi Kanda
Journal:  J Neurol       Date:  2015-06-09       Impact factor: 4.849

6.  Effect of sera from seronegative myasthenia gravis patients on neuromuscular junctions.

Authors:  Rumi Sato; Shiho Imamoto; Iku Utsnomiya; Terumasa Chiba; Kyoji Taguchi; Kenji Abe; Keiko Tanaka; Tadashi Miyatake
Journal:  Neurol Sci       Date:  2013-02-07       Impact factor: 3.307

7.  Topology and patch-clamp analysis of the sodium channel in relationship to the anti-lipid a antibody in campylobacteriosis.

Authors:  Seigo Usuki; Yoshihiko Nakatani; Kyoji Taguchi; Tetsuhiro Fujita; Shinya Tanabe; Iku Ustunomiya; Yihua Gu; Shaun A Cawthraw; Diane G Newell; Mohanasundari Pajaniappan; Stuart A Thompson; Toshio Ariga; Robert K Yu
Journal:  J Neurosci Res       Date:  2008-11-15       Impact factor: 4.164

8.  Cav2.1 voltage-dependent Ca2+ channel current is inhibited by serum from select patients with Guillain-Barré syndrome.

Authors:  Yoshihiko Nakatani; Sayako Hotta; Iku Utsunomiya; Keiko Tanaka; Keiko Hoshi; Toshi Ariga; Robert K Yu; Tadashi Miyatake; Kyoji Taguchi
Journal:  Neurochem Res       Date:  2008-05-14       Impact factor: 3.996

9.  Novel anti-idiotype antibody therapy for lipooligosaccharide-induced experimental autoimmune neuritis: use relevant to Guillain-Barré syndrome.

Authors:  S Usuki; K Taguchi; S A Thompson; P B Chapman; R K Yu
Journal:  J Neurosci Res       Date:  2010-06       Impact factor: 4.164

Review 10.  Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review.

Authors:  Kenichi Kaida; Toshio Ariga; Robert K Yu
Journal:  Glycobiology       Date:  2009-02-24       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.